The Lyme disease vaccine, approved by the Food and Drug Administration in 1998, is important because it may reduce the morbidity
and financial costs associated with Lyme disease. Through the vaccine's unique mechanism, the vaccine works inside the tick
vector itself, preventing humans from becoming infected.